Yoshiyama et al., 1991 - Google Patents
Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factorYoshiyama et al., 1991
- Document ID
- 3827503038990013776
- Author
- Yoshiyama Y
- Arakaki N
- Naka D
- Takahashi K
- Hirono S
- Kondo J
- Nakayama H
- Gohda E
- Kitamura N
- Tsubouchi H
- Ishii T
- Hishida T
- Daikuhara Y
- Publication year
- Publication venue
- Biochemical and biophysical research communications
External Links
Snippet
The N-terminal amino acid of the heavy chain of native (purified from human plasma) and recombinant human hepatocyte growth factor (hHGF) was determined by analyses of amino acid composition and sequence of peptide fragments derived by enzymatic cleavage …
- 102000020664 human HGF protein 0 title abstract description 72
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yoshiyama et al. | Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor | |
Gentry et al. | The pro domain of pre-pro-transforming growth factor. beta. 1 when independently expressed is a functional binding protein for the mature growth factor | |
Adolf et al. | Natural human interferon-α2 is O-glycosylated | |
Imai et al. | Physicochemical and biological comparison of recombinant human erythropoietin with human urinary erythropoietin | |
George-Nascimento et al. | Characterization of recombinant human epidermal growth factor produced in yeast | |
Beg et al. | The primary structure of α‐lactalbumin from camel milk | |
Minamitake et al. | Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cells | |
WO2001081405A2 (en) | Methods and compositions for the prevention and treatment of anemia | |
AU2001255516A1 (en) | Methods and compositions for the prevention and treatment of anemia | |
Broudy et al. | Recombinant human erythropoietin: purification and analysis of carbohydrate linkage | |
US5120535A (en) | Oncostatin M and novel compositions having anti-neoplastic activity | |
IE853082L (en) | Serine protease inhibitors | |
WO1992022320A1 (en) | C1 inhibitor variants and treating inflammatory response with c1 inhibitor | |
Kalafatis et al. | Identification and characterization of a phospholipid-binding site of bovine factor Va. | |
Haniu et al. | Disulfide bonds in recombinant human platelet-derived growth factor BB dimer: characterization of intermolecular and intramolecular disulfide linkages | |
US5359033A (en) | Cleaved dimers of mullerian inhibiting substance-like polypeptides | |
EP0804486B1 (en) | Granulocyte chemotactic protein | |
Peach et al. | Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494Asp→ Asn) | |
Schmelzer et al. | Biochemical characterization of recombinant human nerve growth factor | |
Kim et al. | Purification and characterization of a low molecular weight transforming growth factor from the urine of melanoma patients. | |
Gellerfors et al. | Separation and identification of growth hormone variants with high performance liquid chromatography techniques | |
Lu et al. | Post-translational processing of membrane-associated recombinant human stem cell factor expressed in Chinese hamster ovary cells | |
Lu et al. | Post-translational processing of membrane-associated neu differentiation factor proisoforms expressed in mammalian cells | |
Elliott et al. | Structural requirements for addition of O-linked carbohydrate to recombinant erythropoietin | |
Browning et al. | Disulfide scrambling of interleukin-2: HPLC resolution of the three possible isomers |